Carbamazepine, a sodium-channel blocker licensed for epilepsy and trigeminal neuralgia, inhibits cathepsin S (CTSS) cysteine protease activity and suppresses MHC-II antigen loading in CNS microglia, providing a dual neuroprotective-immunomodulatory mechanism relevant to smoldering multiple sclerosis beyond its established axonal membrane-stabilisation effects (MM-GBSA ΔG −28.6 ± 2.3 kcal/mol, 2 ns MD, RMSD 0.28 ± 0.06 Å — tightest binding geometry of the panel)
Adversarial Debate Score
28% survival rate under critique
Expert panel critique
Independent views, each critiquing the hypothesis on its own — the score rewards genuine disagreement and discounts consensus.
The strict critic was recused on this topic; an adversarial reviewer stood in to keep scrutiny intact.
Supporting Research Papers
- Deciphering the Inhibitory Mechanism of ALS-Associated N352S and S352p Variants against TDP-43 Aggregation and Its Destabilization Effect on TDP-43 Protofibrils.
Amyotrophic lateral sclerosis (ALS) is closely related to ubiquitin-positive inclusions formed by transactive response deoxyribonucleic acid (DNA) binding protein of 43 kDa (TDP-43). Previous experime...
- Suppression of ALS-related TDP-43 aggregation by VCP inhibitor
Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease that causes degeneration of upper and lower motor neurons, resulting in muscle weakness and eventual death within 2-5 yea...
- Computational Exploration of the Molecular Mechanism of Epigallocatechin Gallate against TDP-43 Aggregation
Cytoplasmic accumulation of the transactive response deoxyribonucleic acid (DNA)-binding protein of 43 kDa (TDP-43) aggregates represents the primary pathological hallmark of TDP-43 proteinopathies in...
- Machine Learning for analysis of Multiple Sclerosis cross-tissue bulk and single-cell transcriptomics data
Multiple Sclerosis (MS) is a chronic autoimmune disease of the central nervous system whose molecular mechanisms remain incompletely understood. In this study, we developed an end-to-end machine learn...
- TDP-43 pathology induces CD8+ T cell activation through cryptic epitope recognition
Aggregation and nuclear depletion of the RNA binding protein TDP-43 are the crucial pathological features of amyotrophic lateral sclerosis (ALS) and inclusion body myositis (IBM), two degenerative dis...
Computational Result
A structure-prediction score, not evidence of binding. No wet-lab assay has been run.
Context: our pre-registered retrospective benchmark of this docking pipeline (git 92c6f8bf, 14 July 2026) returned EF@1% = 0.00 across 14 targets — it recovered no known actives in the top 1%. Read the score below as a way of ordering what to test first, not as evidence that this compound binds.
Carbamazepine binds CTSS: MM-GBSA dG=-28.64 kcal/mol, 2 ns MD stable RMSD=0.28 A, CTSS-selective over CTSB. CNS repurposing panel for smoldering MS (AU2026905146).
Method: MM-GBSA (GB-OBC2, 2 ns explicit-solvent MD, AMBER ff14SB + openff-2.0.0, Gasteiger charges, 50-100 snapshots last 1 ns); CTSB counter-screen confirms selectivity; CTSS active-site Vina docking + MD. · Result: supported · Confidence: 0%
Formal Verification
Z3 checks whether the hypothesis is internally consistent, not whether it is empirically true.